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Abstract
Dukhanin and colleagues’ taxonomy of metrics for patient engagement at the organizational and system levels 
has great potential for supporting more careful and useful evaluations of this ever-growing phenomenon. This 
commentary highlights the central importance to the taxonomy of metrics assessing the extent of meaningful 
participation in decision-making by patients, consumers and community members; discusses how the purpose 
of an evaluation and the organizational relationships among key evaluation stakeholders is likely to influence 
the choice of metrics in important ways; and suggests a recasting of the metrics in the form of a logic model 
that supports the selection of metrics that are appropriate for a program given its stage of development and the 
purposes of the study. 
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This commentary is designed to increase the value and utility of the Dukhanin et al1 taxonomy and associated tools, for those who are funding, planning 
or conducting an evaluation of efforts to engage patients 
in healthcare organizational, community or system level 
decision-making. To begin, it is important to recognize that 
at the core of this study is a commitment by the authors to 
the idea of meaningful participation in decision-making by 
individuals who are served by healthcare organizations. The 
authors’ use of Sherry Arnstein’s “ladder of participation” 
is a key indicator of this focus.2 Arnstein’s “ladder” was 
produced during the 1960s, when community participation 
in, indeed control of, decisions about programs intended to 
improve the circumstances of poor and otherwise vulnerable 
populations was a widely held goal of those funding and 
implementing these programs. The authors’ commitment is 
important because attempts at “engagement” can be designed 
not to empower, but to effectively co-opt those served by 
programs. I see little reason to believe that current attempts at 
patient engagement are immune to such agendas. Healthcare 
organizations are far more likely to engage their patients and 
patients’ family members if they believe this will improve 
their own circumstances, eg, their attractiveness to patients 
as a service provider; their reputation in the community; 
and in particular their financial performance. This needs to 
be kept in mind in the choice of metrics to evaluate patient 
engagement efforts at the organizational and system levels.3
As an evaluator and teacher of evaluation, I have learned that 
the first step in designing any evaluation must be to identify 
its purpose(s).4 Why is this evaluation being undertaken? 
Is it a “symbolic” evaluation, designed to demonstrate the 
willingness of program implementers to be “accountable” and 
“transparent” not to mention being aware that the current 
bandwagon has a large sign on it saying “patient engagement”? 
Or is it a research study, designed to carefully assess whether 
a fully implemented innovation does or does not achieve its 
intended goals, to decide if it should be sustained, replicated 
or taken to scale? Might it be a more “formative” evaluation 
whose purpose is to figure out whether and how the program 
has been implemented as intended, and whether, if changes 
in program design have been made, that is the result of 
inadequacy of resources available or careful adaptation to 
local circumstances? The purpose of an evaluation should 
drive the metrics used: whether they focus on outcomes, 
processes, or both; whether they are quantitative, qualitative 
or a mix; whether they are strong, reliable and valid, but most 
important, their content/focus. As an evaluator, actually 
figuring out the true purpose of an evaluation can require 
serious detective work, given that, for example, no one will 
admit they are just doing a symbolic evaluation. Further, 
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different stakeholders may have different preferences as to the 
evaluation’s purpose. Typically, however, whoever funds the 
evaluation calls that tune, which in turn heavily impacts the 
choice of metrics. 
Indeed, evaluation purposes often reflect the organizational 
relationship between the program, the program’s funder, the 
program evaluator, and the funder/selector of the evaluator. 
These relationships typically determine whose purpose 
will be paramount and which metrics will be used to assess 
“success.” Notice that, ironically, this list of key parties has 
historically failed to include the people and the community 
the program is trying to serve, unless one of the other 
actors has already done a really fine job of engagement. The 
increasingly extensive literature in patient participation in 
research, work that Dukhanin and colleagues appropriately 
chose not to examine for this analysis, can actually be useful 
in increasing the involvement of patients in evaluations of 
patient engagement efforts.5,6 This involvement could, indeed, 
include the selection of key metrics for the study. This will 
require evaluators to learn how to do this, and do it well. 
What difference do organizational relationships make? 
Consider, for example, a “third-party” evaluation, in which the 
program funder also selects and funds the evaluator. Almost 
always, such an evaluation will include outcome metrics, 
because funders want to “prove” that they funded something 
that works. All too often, however, they fail to fund careful 
examination of the actual implementation of the program, 
which most often requires use of process metrics, although 
this is changing as everyone realizes that the description of 
many programs is at best preliminary since the realities of 
life tend to ensure that changes will be needed. In the case 
of evaluations of patient engagement efforts, there is a core 
conundrum here, that is reflected in the authors’ metrics. Is 
engagement of sufficient value in itself that strong process 
metrics should be the focus? Or must it be demonstrated that 
engagement leads to consequences that have historically been 
of greater importance to healthcare decision-makers, such as 
improvements in health or health equity, or reductions in cost 
or inappropriate utilization of services? Note that Dukhanin 
and colleagues’ “outcome” metrics actually include many 
of what they call “internal outcomes,” which could well be 
viewed as “initial” or “intermediate” outcomes. These metrics 
include impact on engagement participants’ knowledge, 
skills, empowerment, satisfaction and trust and even impact 
on the organization or system itself, such as staff views 
on engagement, formal organization or system policies or 
explicit changes to decision-making processes. To this reader, 
these intermediate outcomes are addressing the question 
“Did meaningful patient engagement actually take place?” 
which some would consider equivalent to the question “Was 
the intervention fully implemented?” 
Whether we consider these as outcomes or processes, it is 
critical that these issues be addressed. Educational evaluator 
Michael Scriven, decades ago, noted that evaluators have 
to distinguish between “failures of theory” and “failures of 
practice.”7 In this context, if a healthcare organization did 
not in fact implement patient engagement in a genuine and 
complete way, then it is not fair to say patient engagement 
is useless if it did not achieve what the Dukhanin et al call 
“external outcomes” such as actual changes in health status 
and health equity. 
Connecting these metrics in a meaningful way can be 
supported by the development of a robust “logic model” or 
“theory of change” for patient engagement. A logic model 
lays out the assumed sequence of events through which a 
program achieves its goals, moving from inputs through 
processes to outcomes. Avedis Donabedian was a pioneer 
in asserting that the quality of medical care could indeed be 
evaluated systematically rather than simply being reviewed by 
physicians with the same training as the people delivering the 
care. He distinguished three levels of evaluation: structure (or 
in language more common to logic model “inputs”), process, 
and outcomes.8 These levels, and the columns in the logic 
model, are in fact ways to organize the metrics that can be 
used in an evaluation, depending on when and where and 
for what purpose the evaluation is being conducted. Thus, 
when a program is just starting, it is probably wise to focus 
on the inputs and initial outcomes rather than the long-term 
outcomes. The logic model (see Table) derives from the 
author’s experience in designing, conducting and evaluating 
patient engagement activities in healthcare organizations, 
and in constructing logic models. It is primarily populated by 
the metrics in Dukhanin et al and their organization. It has 
the capacity to help evaluators organize the Dukhanin et al 
metrics conceptually and temporally. 
Thus for example, several of the “preconditions for 
engagement” metrics identified in the Dukhanin et al article 
could well be considered structural or “input” measures, or 
“initial process” measures including the number of patients, 
consumers and community members involved in the 
engagement program and their ratio to, for example, hospital 
staff at meetings; the representativeness and accountability of 
the patients, consumers and community members involved; 
the training for staff in patient engagement; and the training of 
the “P2C2 representatives” themselves. I would add, based on 
my experience studying community coalitions and consumer 
dominated governing bodies, whether representatives get 
solid, ongoing support on technical issues, to help create a 
level playing field in discussions and decision making with 
highly training professionals. 
One advantage of logic models is that they provide a 
timeline for evaluators, to ensure that they do not focus 
on certain metrics too early in the process (eg, looking for 
intermediate outcomes too early) or too late (eg, failing to 
make sure that key processes are in place prior to examining 
outcomes). However, logic models can at times oversimplify 
the process through which complex and subtle efforts 
such as patient and community engagement are actually 
implemented. For example, recruiting members to boards 
or committees is often an ongoing task, reflecting the 
difficulties faced by people not getting a salary for important 
work in continuing for long periods of time. This is a metric, 
therefore, that probably needs to be continually revisited over 
the course of implementation and evaluation. Furthermore, 
it is important that these metrics not be reduced to a “check 
the box” approach to assessment of patient and community 
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Table. Logic Model:  Evaluating Programs to Engage P2C2 Reps in Healthcare Organizations
Inputs Initial Processes Eventual Processes Initial Outcomes Intermediate Outcomes Long-term Outcomes
•	 Organizational 
commitment to 
engagement (including 
financial and staff 
resources)
•	 Recruitment of an 
adequate number of 
P2C2 repsa who are 
chosen to, reflect the 
broader population 
being served, who are 
ready to participate 
and have generally 
positive attitudes toward 
engagement
•	 Training is provided for 
staff responsible for 
engagement
•	 Training is provided for 
P2C2 reps
•	 Effective recruitment of P2C2 reps 
using culturally appropriate methods 
and media
•	 A broad, jargon-free initial assessment 
of P2C2 needs and strengths is 
provided to support P2C2 decision-
making
•	 P2C2 reps have control over various 
aspects of decision-making including 
agenda setting; time allocation; having 
defined roles; involvement since first 
stage of decision-making; and control 
over meeting minutes
•	 Meetings are regularly held; P2C2 
reps are not out-numbered by other 
participants; reps attend regularly and 
participate actively
•	 Healthcare organization supports 
dissemination of the results of 
engagement (eg, decisions made)
•	 Decision-making process is 
transparent and trusted; P2C2 
reps participate actively; reps 
participate equally; they are 
treated with respect; they can 
make decisions independently; 
they are involved throughout 
all stages of decision-making, 
including final decisions; they are 
asked to evaluate the decision 
process and can make changes 
in it
•	 The healthcare organization 
assures follow-up of 
commitments and their 
translation into action
•	 All steps in the engagement are 
tailored to the cultural beliefs 
and practices of P2C2 reps
•	 Increase in P2C2 reps readiness 
for and positive attitudes toward 
engagement
•	 Increase in the knowledge and 
relevant skills of P2C2 reps
•	 P2C2 reps are satisfied with the 
engagement; they experience 
increases in empowerment vis a 
vis healthcare and increases in 
their own trust of the healthcare 
organization
•	 Staff views of engagement become 
more positive
•	 Explicit changes are made to 
organization or system process of 
decision-making
•	 Formal (written) organizational or 
system policies are developed
•	 The availability of funding and 
other resources increasesb
•	 Healthcare organization 
experiences improvements in 
efficiency and cost-effectiveness 
of their services; service 
availability, quality and safety; 
service responsiveness to patient 
and community needs; and more 
appropriate use of servicesc
•	 Additional connections or 
partnerships are developed with 
other groups and organizations
•	 Organization or system becomes 
more accountable to P2C2 they 
serve
•	 The visibility of the organization 
or system increases
•	 Relevant publics 
become more aware or 
knowledgeable about 
health issues
•	 Relevant publics and 
community gives 
great support to the 
organization or system
•	 Population health 
improves
•	 Health inequalities are 
reduced
•	 Overall, the P2C2 effort is 
cost-effective 
a P2C2 stands for Patient, Public, Consumer and Community.  “Reps” stands for representatives.
b Unclear if this means external resources coming to health care organization/system or more resources being assigned to P2C2 activities.
c Depending on the situation, this could mean either more or less use of specific services. 
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engagement. The processes involved are subtle and nuanced; 
the “scores” should rarely be simply “yes/no” dichotomies. 
Hopefully, this alternative presentation of the metrics will 
be of value to the field and make it easier to use them in the 
important job of moving the field of patient and community 
engagement forward, especially at the organizational rather 
than the individual level.
Ethical issues
Not applicable.
Competing interests
Author declares that she has no competing interests. 
Author’s contribution
SS is the single author of the paper. 
References
1. Dukhanin V, Topazian R, DeCamp M. Metrics and Evaluation Tools 
for Patient Engagement in Healthcare Organization- and System-
Level Decision-Making: A Systematic Review. Int J Health Policy 
Manag. 2018;7(10):889-903. doi:10.15171/ijhpm.2018.43
2. Arnstein SR. A ladder of citizen participation. J Am Inst Plann. 
1969;35(4):216-224. doi:10.1080/01944366908977225 
3. Carman KL, Dardess P, Maurer M, et al. Patient and family 
engagement: a framework for understanding the elements and 
developing interventions and policies. Health Aff (Millwood). 
2013;32(2):223-231. doi:10.1377/hlthaff.2012.1133
4. Churgin S. Evaluation. In: Blum HR, ed. Planning for Health. 2nd ed. 
New York, NY: Human Sciences Press; 1981.
5. Shippee ND, Domecq Garces JP, Prutsky Lopez GJ, et al. Patient 
and service user engagement in research: a systematic review 
and synthesized framework. Health Expect. 2015;18(5):1151-1166. 
doi:10.1111/hex.12090 
6. Frank L, Forsythe L, Ellis L, et al. Conceptual and practical 
foundations of patient engagement in research at the patient-centered 
outcomes research institute. Qual Life Res. 2015;24(5):1033-1041. 
doi:10.1007/s11136-014-0893-3 
7. Scriven M. Evaluation Bias and its Control. In: Glass G. Eval Studies 
Rev Ann, Vol. 1. Beverly Hills, CA: Sage Publications; 1976.
8. Donabedian A. Twenty years of research on the quality of 
medical care: 1964-1984. Eval Health Prof. 1985;8(3):243-265. 
doi:10.1177/016327878500800301
